510 related articles for article (PubMed ID: 7542672)
21. Inhibiting scar formation in rat wounds by adenovirus-mediated overexpression of truncated TGF-beta receptor II.
Liu W; Chua C; Wu X; Wang D; Ying D; Cui L; Cao Y
Plast Reconstr Surg; 2005 Mar; 115(3):860-70. PubMed ID: 15731688
[TBL] [Abstract][Full Text] [Related]
22. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
Ferguson MW; O'Kane S
Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
[TBL] [Abstract][Full Text] [Related]
23. Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition.
Beanes SR; Hu FY; Soo C; Dang CM; Urata M; Ting K; Atkinson JB; Benhaim P; Hedrick MH; Lorenz HP
Plast Reconstr Surg; 2002 Jan; 109(1):160-70. PubMed ID: 11786808
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: results of two preclinical and phase II randomized control studies.
Kieran I; Knock A; Bush J; So K; Metcalfe A; Hobson R; Mason T; O'Kane S; Ferguson M
Wound Repair Regen; 2013; 21(3):428-36. PubMed ID: 23627460
[TBL] [Abstract][Full Text] [Related]
25. siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue.
Wang YW; Liou NH; Cherng JH; Chang SJ; Ma KH; Fu E; Liu JC; Dai NT
J Invest Dermatol; 2014 Jul; 134(7):2016-2025. PubMed ID: 24670383
[TBL] [Abstract][Full Text] [Related]
26. Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing.
Kim YS; Lew DH; Tark KC; Rah DK; Hong JP
J Korean Med Sci; 2010 Apr; 25(4):589-96. PubMed ID: 20358003
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis.
Lichtman MK; Otero-Vinas M; Falanga V
Wound Repair Regen; 2016 Mar; 24(2):215-22. PubMed ID: 26704519
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
Pierce GF; Tarpley JE; Yanagihara D; Mustoe TA; Fox GM; Thomason A
Am J Pathol; 1992 Jun; 140(6):1375-88. PubMed ID: 1376557
[TBL] [Abstract][Full Text] [Related]
29. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides.
Choi BM; Kwak HJ; Jun CD; Park SD; Kim KY; Kim HR; Chung HT
Immunol Cell Biol; 1996 Apr; 74(2):144-50. PubMed ID: 8724001
[TBL] [Abstract][Full Text] [Related]
30. Systemic Delivery of Anti-Integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn Wounds.
Strudwick XL; Adams DH; Pyne NT; Samuel MS; Murray RZ; Cowin AJ
Adv Wound Care (New Rochelle); 2020 Dec; 9(12):637-648. PubMed ID: 33124967
[No Abstract] [Full Text] [Related]
31. Release of insulin from PLGA-alginate dressing stimulates regenerative healing of burn wounds in rats.
Dhall S; Silva JP; Liu Y; Hrynyk M; Garcia M; Chan A; Lyubovitsky J; Neufeld RJ; Martins-Green M
Clin Sci (Lond); 2015 Dec; 129(12):1115-29. PubMed ID: 26310669
[TBL] [Abstract][Full Text] [Related]
32. Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-β3 signaling.
Zheng Z; Nguyen C; Zhang X; Khorasani H; Wang JZ; Zara JN; Chu F; Yin W; Pang S; Le A; Ting K; Soo C
J Invest Dermatol; 2011 Mar; 131(3):769-78. PubMed ID: 21191417
[TBL] [Abstract][Full Text] [Related]
33. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.
Occleston NL; Laverty HG; O'Kane S; Ferguson MW
J Biomater Sci Polym Ed; 2008; 19(8):1047-63. PubMed ID: 18644230
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta2 (TGF-beta2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig.
Petratos PB; Felsen D; Trierweiler G; Pratt B; McPherson JM; Poppas DP
Wound Repair Regen; 2002; 10(4):252-8. PubMed ID: 12191008
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing.
Beanes SR; Dang C; Soo C; Wang Y; Urata M; Ting K; Fonkalsrud EW; Benhaim P; Hedrick MH; Atkinson JB; Lorenz HP
J Pediatr Surg; 2001 Nov; 36(11):1666-71. PubMed ID: 11685698
[TBL] [Abstract][Full Text] [Related]
36. [The modern approach to wound treatment].
Komarcević A
Med Pregl; 2000; 53(7-8):363-8. PubMed ID: 11214479
[TBL] [Abstract][Full Text] [Related]
37. Novel therapies for scar reduction and regenerative healing of skin wounds.
Rhett JM; Ghatnekar GS; Palatinus JA; O'Quinn M; Yost MJ; Gourdie RG
Trends Biotechnol; 2008 Apr; 26(4):173-80. PubMed ID: 18295916
[TBL] [Abstract][Full Text] [Related]
38. Experimental manipulation of transforming growth factor-beta isoforms significantly affects adhesion formation in a murine surgical model.
Gorvy DA; Herrick SE; Shah M; Ferguson MW
Am J Pathol; 2005 Oct; 167(4):1005-19. PubMed ID: 16192636
[TBL] [Abstract][Full Text] [Related]
39. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair.
Adzick NS; Lorenz HP
Ann Surg; 1994 Jul; 220(1):10-8. PubMed ID: 8024353
[TBL] [Abstract][Full Text] [Related]
40. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair.
Lin RY; Sullivan KM; Argenta PA; Meuli M; Lorenz HP; Adzick NS
Ann Surg; 1995 Aug; 222(2):146-54. PubMed ID: 7639582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
